Aurobindo Pharma's net debt to EBITDA ratio FY 2013-2023

Published by A. Minhas, Aug 28, 2023
In fiscal year 2023, Aurobindo Pharma's net debt to EBITDA ratio was negative 0.33, down from fiscal year 2020. The net profit of the pharmaceutical company before taxes was over 19 billion Indian rupees in financial year 2023.

Net debt to EBITDA ratio of Aurobindo Pharma Limited from financial year 2013 to 2023

© Statista 2024
Download
Show detailed source information?
Register for free
Already a member?
Log in
Source

Use Ask Statista Research Service

Release date

August 2023

Region

India

Survey time period

FY 2013 to FY 2023

Supplementary notes

EBITDA refers to earnings before interest, tax, depreciation and amortization. Financial analysts use the net debt to EBITDA ratio to determine a company’s ability to pay its debt. A high ratio of net debt to EBITDA reveals a company that is deep in debt and vice versa for a low ratio.

*Includes higher sales from limited competition product.

India's fiscal year starts in April and ends in March. For example, FY 2018 started in April 2017 and ended in March 2018.

Citation formats
Statista Accounts: Access All Statistics. Starting from $2,388 USD / Year
Basic Account
Get to know the platform

You only have access to basic statistics.
This statistic is not included in your account.

Starter Account
The ideal entry-level account for individual users
  • Instant access to 1m statistics
  • Download in XLS, PDF & PNG format
  • Detailed references
$199 USD / Month *
Professional Account
Full access

Business Solutions including all features.

* Prices do not include sales tax.

Other statistics that may interest you

The most important statistics
The most important statistics
The most important statistics
The most important statistics
The most important statistics

Other statistics that may interest you Statistics on

About the industry

10

About the region

10

Selected statistics

1

Other regions

10

Related statistics

10

Further related statistics

9

Further Content: You might find this interesting as well

Statistics

Topics

Merck & Co.Global pharmaceutical industryPharmaceutical industry in the U.S.Top pharmaceutical drugsPfizer
Statista Accounts: Access All Statistics. Starting from $2,388 USD / Year
Learn more about how Statista can support your business.
Menu